Danske Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Danske Bank's CRL Position: Q3 2026 in Review
Danske Bank held its Charles River Laboratories (CRL) position steady in Q3 2026 at 100 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #706.
Danske Bank first reported a position in CRL in Q1 2024 and has held it in 11 quarters since. The position peaked at $10.2M in Q4 2025. 515 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Danske Bank held 100 shares of Charles River Laboratories worth $29.5K as of Q3 2026.
- Danske Bank left its Charles River Laboratories share count unchanged in Q3 2026.
- Charles River Laboratories made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #706 holding.
- Danske Bank first reported a position in Charles River Laboratories in Q1 2024 and has held it in 11 quarters since.
- Danske Bank's Charles River Laboratories position peaked at $10.2M in Q4 2025.
- 515 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.